Aluminum compounds for use in therapeutics and vaccines

Patent metadata

Field	Value
Publication number	US-9884115-B2
Application number	US-201514873344-A
Country	US
Kind code	B2
Filing date	Oct 2, 2015
Priority date	Apr 18, 2012
Publication date	Feb 6, 2018
Grant date	Feb 6, 2018

Abstract

The invention relates to means and methods for preparing aqueous composition comprising aluminium and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminium content. The invention further relates to aqueous compositions comprising a protein and an aluminium-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.

First claim

What is claimed is:

1. A method for preparing an aqueous composition comprising aluminium, a reactive compound and a protein antigen, said method comprising selecting an aluminium-salt to provide an aqueous composition having less than 3 ppb Cu based on the weight of the aqueous composition and combining said aluminium salt, said reactive compound, said protein antigen and water to produce said aqueous composition.

2. The method according to claim 1 , further comprising buffering said aqueous composition at a pH of between 6.5 and 8.5.

3. The method according to claim 1 , further comprising packaging aliquots of said aqueous composition in separate air-tight storage containers.

4. A method for preparing a clinical grade aluminium-salt precipitate for incorporation into a medicament and/or vaccine, said method comprising preparing an aqueous solution of aluminium ions and precipitating said aluminium-ions from said solution, determining the level of a heavy metal in the solution and/or the aluminium-salt precipitate, and selecting a precipitate to provide an aqueous composition comprising less than 3 ppb Cu based on the weight of the aqueous composition.

5. The method according to claim 1 , wherein the reactive compound is selected from the group consisting of a redox active compound, a radical building compound, a stabilizing compound and a combination of any thereof.

6. The method according to claim 1 , wherein the protein antigen is a protein of the Japanese encephalitis virus.

7. A method for preparing an aqueous composition comprising aluminium, a reactive compound and a protein antigen, comprising selecting an aluminium-salt that is able to provide an aqueous composition having between 5 microgram/ml and 50 milligram/ml aluminium and having less than 3 ppb Cu based on the weight of the aqueous composition and combining said aluminium salt, said reactive compound, said protein antigen and water to produce said aqueous composition having between 5 microgram/ml and 50 milligram/ml aluminium.

8. The method according to claim 7 , wherein the reactive compound is selected from the group consisting of a redox active compound, a radical building compound, a stabilizing compound and a combination of any thereof.

9. The method according to claim 7 , further comprising buffering said aqueous composition at a pH of between 6.5 and 8.5.

10. The method according to claim 7 , further comprising packaging aliquots of said aqueous composition in separate air-tight storage containers.

11. The method according to claim 7 , wherein the protein antigen is a protein of the Japanese encephalitis virus.

12. The method according to claim 1 , wherein the aluminium-salt is selected to provide an aqueous composition having less than 2.5 ppb Cu based on the weight of the aqueous composition.

13. The method according to claim 4 , wherein the precipitate is selected to provide an aqueous composition comprising less than 2.5 ppb Cu based on the weight of the aqueous composition.

14. The method according to claim 7 , wherein the aluminium-salt is selected to provide an aqueous composition comprising less than 2.5 ppb Cu based on the weight of the aqueous composition.

Assignees

• Valneva Austria Gmbh

Inventors

• Schlegl Robert
• Moehlen Michael
• Wruss Juergen
• Weber Michael

Classifications

• A61P31/04

  Antibacterial agents · CPC title

• A61P37/04

  Immunostimulants · CPC title

• A61P31/12

  Antivirals · CPC title

• A61K2039/55505

  Inorganic adjuvants · CPC title

• A61K38/162

  from virus · CPC title